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orophylactic Coronary
ngiography Improves Outcome
fter Major Vascular Surgery
n a study published recently in the Journal, Monaco et al. (1)
howed that routine coronary angiography positively impacted
ong-term outcome of peripheral arterial disease surgical patients
t medium-high risk.
I find it difficult to adopt this study’s results for the following
easons. Two randomized studies showed no benefit for percu-
aneous coronary intervention (PCI) in elective patients under-
oing vascular surgery (2,3). Actually, despite numerous at-
empts, no randomized study to date has shown PCI to improve
lective patient prognosis (4 –8). A diagnostic procedure (e.g.,
oronary angiography) should not be expected to improve
atient prognosis, unless followed by an intervention (e.g.,
CI). In the current study (1), however, the differences in PCI
ate in the “systematic strategy” compared with the “selective strategy”
roup was very small: 61 (58%) versus 42 (40%), respectively. To reach
tatistical significance, therefore, the impact of PCI on a patient’s
rognosis should be huge. Considering the previous studies, I find
t unlikely.
Furthermore, long-term dual-antiplatelet therapy is currently
he standard treatment for patients undergoing coronary artery
tenting. That may postpone surgery for a significant time because
f increased bleeding risk.
We definitely need a multicenter trial to resolve this issue. Until
he results of such a trial are available, we should continue to
ractice according to current guidelines (9) and not change practice
s a result of this study.
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rophylactic Pre-Operative
oronary Revascularization
o We Have the Data?
onaco et al. (1) propose a new diagnostic and treatment
lgorithm for patients undergoing major elective vascular surgery
ith a revised cardiac risk index (RCRI) 2: routine coronary
ngiography followed by extensive revascularization. In their dis-
ussion, the authors presumed that this algorithm yielded superior
esults (when compared with the conventional algorithm of selec-
ive coronary angiography based on noninvasive stress imaging)
ecause “. . . noninvasive testing missed a substantial portion of
atients with coronary artery disease (CAD).”
This statement is not substantiated by the study. The authors
ould have extracted the data in an attempt to support or validate
his statement by comparing the negative predictive values of
he 2 strategies. It is common teaching that both noninvasive
ests (2,3) employed in this study for the “selective strategy”
ave excellent negative predictive values and low positive
redictive value and can enhance the value of selective revascu-
arization in ischemic patients (4).
Because of the very few cardiovascular events and because there
as no significant difference between the 2 arms in the frequency
f myocardial infarctions (3.9 vs. 1.9, p  0.5), the quality of the
aper could have been enhanced by precise description and
a
0
w
s
b
i
t
u
s

v
T
c
r
w
i
f
s
0
e
p
t
p
c
i
w
d
t
*
*
U
1
N
E
R
1
2
3
4
5
A
M
U
A
E
I
e
i
n
p
s
m
a
b
r
p
M
p
a
p
b
w
t
d
d
d
t
B
s
s
b
h
a
w
s
e
v
U
i
r
R
D
*
*
H
S
8
H
E
1397JACC Vol. 55, No. 13, 2010 Correspondence
March 30, 2010:1396–400djudication of the “cardiac mortality” events (6.8% vs. 1.9%, p 
.08) as well as the long-term mortality data in this elderly cohort
ith multiple comorbidities.
The paper leaves us with a few unsettled issues. 1) Are we
upposed to endorse near-complete revascularization merely
ased on coronary angiography and in the absence of supportive
nformation regarding the clinical significance of the lesions and
he documentation of ischemia and viability in the segments
ndergoing revascularization? Were these data obtained at any
tage on any of the “systemic strategy” patients? 2) Is the RCRI
2 a sufficient predictor of events in patients undergoing major
ascular surgery to undergo mandatory coronary angiography?
his is not supported by the CARP (Coronary Artery Revas-
ularization Prophylaxis) data, which showed that coronary
evascularization did not impart a survival benefit in patients
ith higher RCRI (n  248; odds ratio: 1.2, 95% confidence
nterval: 0.76 to 1.89); however, revascularization seemed to
avorably affect long-term survival in patients with large perfu-
ion defects (n  37; odds ratio: 3.96, 95% confidence interval:
.82 to 19.11) (5). Indeed, other predictors of mortality
merged from the CARP trial (5). 3) Are bare-metal stents the
referred mode for multivessel percutaneous coronary interven-
ion in a cohort that is composed of 38.8% to 37.1% diabetic
atients? 4) Were there no vascular, bleeding, and renal
omplications during or after both angiography and revascular-
zation procedures in this senior cohort (mean age 74 years)
ith peripheral vascular disease with a high proportion of
iabetes mellitus and renal insufficiency (more than one-third of
he patients had creatinine 1.7 mg/dl)?
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351:2795–804.re Long-Term Outcomes of
edium- to High-Risk Patients
ndergoing Vascular Surgery
ffected by the Ischemia
valuation Strategy?
n their recently published paper, Monaco et al. (1) examined the
fficacy of 2 different strategies for pre-operative risk stratification
n patients requiring vascular surgery. The selective strategy used
oninvasive testing for ischemia followed by angiography in
atients identified as potential high-risk surgical candidates. The
ystematic strategy used coronary angiography as the primary
eans of risk stratification. In medium- to high-risk patients, the
uthors conclude that routine coronary angiography produced
etter long-term outcomes. Similar to this study, 2 previous
andomized controlled trials have reported no difference in 30-day
ost-operative outcomes (2,3). In contrast to the results from
onaco et al. (1), neither trial reported any long-term benefit from
re-operative coronary revascularization.
We believe that the discrepant result between Monaco et al. (1)
nd the previous trials may be due to the methodology used in the
resent study. All patients, regardless of randomization, received
eta-adrenergic receptor antagonists, and doses in both groups
ere titrated to achieve a resting heart rate 60 beats/min. Only
hen did the patients in the selective strategy group undergo
ipyridamole–thallium scintigraphy or dobutamine stress echocar-
iography. Both the presence and severity of coronary artery
isease are underestimated in patients receiving beta-blocker
herapy before vasodilator myocardial perfusion imaging (4–6).
eta-blockade has also been reported to reduce the sensitivity and
everity of detection of coronary artery stenosis during dobutamine
tress echocardiography (7–9). The ubiquitous use of beta-
lockade in Monaco et al. (1), while clinically appropriate, may
ave produced false negative results within the selective strategy
rm, and limited the accurate detection of high-risk patients
ithin that group.
Such a result would grant an illusory advantage to the
ystematic strategy. To date, there is still no convincing
vidence that pre-operative coronary revascularization before
ascular surgery improves 30-day post-operative outcomes.
niversal angiography for risk stratification of patients requir-
ng vascular surgery deserves further careful investigation before
outine adoption can be supported.
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